Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| BetterAge | 2025 | Grant | $3.0M | Sunnyside |
| MicroPure Genomics | 2025 | Grant | $300K | San Diego |
| TruDiagnostic | 2025 | Grant | $321K | Lexington |
| Immuto Scientific | 2025 | Seed | $8.0M | Madison |
| RealSeq Biosciences | 2025 | Grant | $2.0M | Santa Cruz |
| Vast Therapeutics | 2025 | Grant | Undisclosed | Morrisville |
| LUCID DIAGNOSTICS INC. | 2025 | Post Ipo Equity | $26.9M | New York |
| Aavogen | 2025 | Grant | $350K | Rockville |
| Lactiga | 2025 | Grant | Undisclosed | Princeton |
| PediaMetrix | 2025 | Grant | $2.0M | Rockville |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 76 | BetterAge | Grant | $3.0M | Sunnyside, United States |
| 77 | MicroPure Genomics | Grant | $300K | San Diego, United States |
| 78 | TruDiagnostic | Grant | $321K | Lexington, United States |
| 79 | Immuto Scientific | Seed | $8.0M | Madison, United States |
| 80 | RealSeq Biosciences | Grant | $2.0M | Santa Cruz, United States |
| 81 | Vast Therapeutics | Grant | Undisclosed | Morrisville, United States |
| 82 | LUCID DIAGNOSTICS INC. | Post Ipo Equity | $26.9M | New York, United States |
| 83 | Aavogen | Grant | $350K | Rockville, United States |
| 84 | Lactiga | Grant | Undisclosed | Princeton, United States |
| 85 | PediaMetrix | Grant | $2.0M | Rockville, United States |
BetterAge provides a personalized, web-based program to help individuals improve health and well-being.
Redefining Sample Preparation, Revolutionizing Genomics
TruDiagnostic is a biodata research company that offers epigenetic testing and research services.
Immuto Scientific is a biotechnology services company that provides analytical insights to pharmaceutical companies for drug discovery.
RealSeq Biosciences’ core expertise includes innovative proprietary technologies for bias-free small RNA/miRNA NGS library construction.
Vast Therapeutics is an innovative, preclinical-stage pharmaceutical company .
Lucid Diagnostics develops a non-invasive, office based diagnostic test for biomarkers to esophageal cancer.
Aavogen is a biotech startup that develops gene therapeutics for muscle wasting diseases.
Lactiga is a biotherapeutics company advancing its patented biologics to transform the anti-infective sector and protect vulnerable patients
PediaMetrix brings AI and computer vision to pediatric health to lower cost and improve outcome.
C. Light Technologies is a developer of a retinal eye-tracking platform used to improve the monitoring of neurodegenerative diseases.
Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications for CNS-based disorders.
Autonomous Healthcare is a medical technology company pioneering the use of automation in clinical care workflows
Atantares is a company that makes smart chips that empower medical technology.
Venova is creating a unique method of birth control for women that is long-acting, extremely effective, and free of adverse effects.
Gel4Med is the Smart Materials Company paving the way to the future of regenerative medicine.
Sur180 Therapeutics is a female-led business that focuses on novel ways to treating gynecological diseases.
Bright Uro is an early-stage medical technology company.
Syntis Bio operates as a late-stage preclinical company that develops oral therapies for obesity, diabetes, and rare diseases.
Opticyte is transforming care for the leading causes of organ failure, including sepsis, with real-time measurements.
Spike Neuro is a biotechnology company that offers neural research device performance using innovative materials and engineering design.
eXoZymes specializes in enzyme design and the development of cell-free enzymatic pathways.
DIMERx operates as a biopharmaceutical company.
28bio is a neurotechnology company that develops brain-on-a-chip platform designed to capture neurological processes.
BiaCure Therapies an emerging innovator in non-invasive medical technology,
National Institutes of Health has invested in 288 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Biotechnology, Health Care, Medical Device, Pharmaceutical, Medical. The firm invests across 22 different industry categories.
Among tracked funding rounds, Syntis Bio received $33.0M in a Series A round. National Institutes of Health's total known invested capital is $1.3B.
National Institutes of Health's average investment size is $6.6M across its portfolio of 288 companies.
Recent National Institutes of Health portfolio additions include BetterAge, MicroPure Genomics, TruDiagnostic, Immuto Scientific, RealSeq Biosciences. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors